COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years. Here, we review the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase.
From the Blog
Aims and scope
Human Genomics is a peer-reviewed, open access journal that focuses on the application of genomic analysis in all aspects of human health and disease, as well as genomic analysis of drug efficacy and safety, and comparative genomics.
Xiaoming Shi, MD/PhD, Director of the National Institute of Environmental Health (NIEH), Chinese Center for Disease Control and Prevention (China CDC)
Nikolaos S. Thomaidis, Professor of Analytical Chemistry, Department of Chemistry, National & Kapodistrian University of Athens
Over the past several decades, genomic analyses (e.g., genome-wide association studies, genome-wide sequencing, functional genomics, epigenomics, and biochemical networks) have enabled unparalleled elucidation of genotype-phenotype associations, which greatly improve our understanding of the pathogenesis of human diseases.
Human Genomics launched with BioMed Central in July 2012, transferring from its previous publisher Henry Stewart Publications. All back content is now available in the archive.
Annual Journal Metrics
39 days to first decision for all manuscripts (Median)
92 days to first decision for reviewed manuscripts only (Median)
461,525 Downloads (2021)
683 Altmetric mentions (2021)